Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer

1. Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling

   Harikumar Pallathadka, Abdulrahman Qais Khaleel, Ahmed Hussein Zwamel +7

   Sharh maqolaImmune Response and InflammationCell Biochemistry and Biophysics20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.review-article.000052

2. Exploring the modulation of TLR4 and its associated ncRNAs in cancer immunopathogenesis, with an emphasis on the therapeutic implications and mechanisms underlying drug resistance

   Mohammad Y. Alshahrani, Enwa Felix Oghenemaro, Jasur Rizaev +7

   Sharh maqolaImmune Response and InflammationHuman Immunology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.review-article.000067